Press releases
Browse US-specific press releases here.
Please visit our Global website for access to global press releases dating back to 2009.
-
GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older (1)
GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older (1)
-
GSK supports a healthy and happy Triangle with $400,000
GSK IMPACT Award winners build healthy communities by addressing care of elders, homelessness, education and other pressing issues
-
GSK celebrates 20 years of a healthy and happy Philadelphia
Ten nonprofits will receive $40,000 to support youth sports, safety, housing, and other pressing community health needs
-
GSK announces $200,000 grant to East Durham Children’s Initiative
Kids lead the way to develop healthier lifestyles
-
GSK unveils campaign to help prevent meningitis
Parents, young adults urged to educate themselves about meningitis B, responsible for one-third of U.S. cases
-
FDA Approves FLONASE® Sensimist™ Allergy Relief
FDA Approves FLONASE® Sensimist™ Allergy Relief.
-
GSK ships 2016-17 seasonal influenza vaccines for US market
- First-to-market with quadrivalent vaccine - Company to deliver up to 40 million doses
-
Update on GSK's response to the Zika virus disease outbreak
Since the outbreak of Zika virus disease began in the Americas late last year, GSK has been assessing how we can best help to respond.
-
GSK Uncovers The State of Uncontrolled Asthma in America
National survey of uncontrolled asthma patients finds majority mistakenly believe their asthma is under control
-
Free GSK Science in the Summer™ classes return to Philadelphia for the 30th year
When school is out, science is in! Online registration begins in May, space is limited.
-
$1 million GSK IMPACT Grant awarded to build healthy futures for young people aging out of foster care in the Triangle
$1 million GSK IMPACT Grant awarded to build healthy futures for young people aging out of foster care in the Triangle.
-
GSK Science in the Summer™ expands to 20 national locations for 30th anniversary
Free summer science program will teach thousands of kids how electricity powers our daily lives
-
GSK, United Way of Greater Philadelphia and Southern New Jersey Issue Call for Applications for 20th Anniversary GSK IMPACT Awards Totaling $400,000
Local nonprofits working to build a healthier community encouraged to apply for ten $40,000 awards
-
GSK, Triangle Community Foundation Issue Call for Applications for GSK IMPACT Awards Totaling $400,000
Local nonprofits working to build a healthier community encouraged to apply for ten $40,000 awards
-
GSK announces US regulatory submission seeking expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 mos+ (1)
GSK announced the submission of a supplemental Biologics License Application (sBLA) to the US FDA for FLULAVAL® QUADRIVALENT
-
FDA approves expanded use of GSK Hib vaccine from booster dose to full series
GSK announced that the US FDA approved an expanded age indication for HIBERIX® [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)].
